Antitumor activity of concurrent blockade of immune checkpoint molecules CTLA-4 and PD-1 in preclinical models.
Mark Selby
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
John Engelhardt
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Li-Sheng Lu
Employment or Leadership Position - Bristol-Myers Squibb
Michael Quigley
Employment or Leadership Position - Bristol-Myers Squibb
Changyu Wang
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Bingliang Chen
Employment or Leadership Position - Bristol-Myers Squibb
Alan J. Korman
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb